Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
{{output}}
Background: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC). Objecti... ...
